

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06851298 |
| 2 | urea metabolic process (GO:0019627) | 3.97433874 |
| 3 | urea cycle (GO:0000050) | 3.97433874 |
| 4 | cell adhesion mediated by integrin (GO:0033627) | 3.84784372 |
| 5 | phospholipid homeostasis (GO:0055091) | 3.78239340 |
| 6 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.75465328 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.66474618 |
| 8 | nitrogen cycle metabolic process (GO:0071941) | 3.57471907 |
| 9 | skin morphogenesis (GO:0043589) | 3.39315352 |
| 10 | regulation of cholesterol homeostasis (GO:2000188) | 3.30456689 |
| 11 | macroautophagy (GO:0016236) | 3.29938231 |
| 12 | pericardium development (GO:0060039) | 3.26257995 |
| 13 | regulation of ARF protein signal transduction (GO:0032012) | 3.25566122 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.24908656 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.24908656 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14069669 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.11239421 |
| 18 | complement activation, alternative pathway (GO:0006957) | 3.07222135 |
| 19 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.02250707 |
| 20 | establishment of protein localization to Golgi (GO:0072600) | 3.01266880 |
| 21 | hypotonic response (GO:0006971) | 2.97699199 |
| 22 | sodium ion export (GO:0071436) | 2.96624332 |
| 23 | positive regulation of fibroblast migration (GO:0010763) | 2.94841454 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.94754555 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.94003354 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 2.94003354 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 2.93111434 |
| 28 | kynurenine metabolic process (GO:0070189) | 2.92701760 |
| 29 | substrate-dependent cell migration (GO:0006929) | 2.92142386 |
| 30 | protein carboxylation (GO:0018214) | 2.91641097 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.91641097 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 2.91424955 |
| 33 | protein-lipid complex assembly (GO:0065005) | 2.88200883 |
| 34 | collagen fibril organization (GO:0030199) | 2.85958075 |
| 35 | regulation of protein activation cascade (GO:2000257) | 2.84822000 |
| 36 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.84231275 |
| 37 | homocysteine metabolic process (GO:0050667) | 2.82960975 |
| 38 | glutamate metabolic process (GO:0006536) | 2.81948461 |
| 39 | positive regulation of lipid catabolic process (GO:0050996) | 2.81196639 |
| 40 | reverse cholesterol transport (GO:0043691) | 2.81021361 |
| 41 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.78727854 |
| 42 | plasma lipoprotein particle assembly (GO:0034377) | 2.78688608 |
| 43 | protein targeting to Golgi (GO:0000042) | 2.76469604 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 2.76253832 |
| 45 | phospholipid efflux (GO:0033700) | 2.75628345 |
| 46 | endodermal cell differentiation (GO:0035987) | 2.75461603 |
| 47 | phospholipid translocation (GO:0045332) | 2.74903681 |
| 48 | lipid translocation (GO:0034204) | 2.74903681 |
| 49 | cholesterol efflux (GO:0033344) | 2.74674651 |
| 50 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.73019425 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 2.71181980 |
| 52 | negative regulation of sterol transport (GO:0032372) | 2.71181980 |
| 53 | bile acid biosynthetic process (GO:0006699) | 2.71112152 |
| 54 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.69894335 |
| 55 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68979374 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 2.68259234 |
| 57 | regulation of complement activation (GO:0030449) | 2.66994319 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 2.66186070 |
| 59 | cellular response to interferon-alpha (GO:0035457) | 2.66173517 |
| 60 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.65405753 |
| 61 | iron ion import (GO:0097286) | 2.65335361 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.64027896 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 2.63748044 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 2.63748044 |
| 65 | tryptophan catabolic process (GO:0006569) | 2.63748044 |
| 66 | cellular response to ethanol (GO:0071361) | 2.63606022 |
| 67 | lysine metabolic process (GO:0006553) | 2.63110156 |
| 68 | lysine catabolic process (GO:0006554) | 2.63110156 |
| 69 | triglyceride homeostasis (GO:0070328) | 2.61313855 |
| 70 | acylglycerol homeostasis (GO:0055090) | 2.61313855 |
| 71 | cysteine metabolic process (GO:0006534) | 2.60672587 |
| 72 | mannose metabolic process (GO:0006013) | 2.60472431 |
| 73 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.58826776 |
| 74 | negative regulation of anoikis (GO:2000811) | 2.58640569 |
| 75 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.58519731 |
| 76 | bile acid metabolic process (GO:0008206) | 2.56492876 |
| 77 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.53838246 |
| 78 | tryptophan metabolic process (GO:0006568) | 2.53649601 |
| 79 | regulation of fibroblast migration (GO:0010762) | 2.53265875 |
| 80 | positive regulation of receptor recycling (GO:0001921) | 2.52371234 |
| 81 | valine metabolic process (GO:0006573) | 2.52146814 |
| 82 | regulation of bile acid biosynthetic process (GO:0070857) | 2.51407159 |
| 83 | chondrocyte proliferation (GO:0035988) | 2.51398227 |
| 84 | protein localization to endosome (GO:0036010) | 2.50753086 |
| 85 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.49873819 |
| 86 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.49769029 |
| 87 | lipoprotein transport (GO:0042953) | 2.49430709 |
| 88 | regulation of fibrinolysis (GO:0051917) | 2.47553906 |
| 89 | growth hormone receptor signaling pathway (GO:0060396) | 2.47064776 |
| 90 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.47014347 |
| 91 | membrane raft organization (GO:0031579) | 2.46496589 |
| 92 | stress fiber assembly (GO:0043149) | 2.45309292 |
| 93 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.45287675 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.45232243 |
| 95 | cell-substrate junction assembly (GO:0007044) | 2.44217405 |
| 96 | fibroblast migration (GO:0010761) | 2.43168376 |
| 97 | positive regulation of histone deacetylation (GO:0031065) | 2.42871991 |
| 98 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42582123 |
| 99 | plasma lipoprotein particle remodeling (GO:0034369) | 2.42244418 |
| 100 | protein-lipid complex remodeling (GO:0034368) | 2.42244418 |
| 101 | macromolecular complex remodeling (GO:0034367) | 2.42244418 |
| 102 | cortical actin cytoskeleton organization (GO:0030866) | 2.41818379 |
| 103 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.40095819 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.40095819 |
| 105 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.39382401 |
| 106 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.39332338 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.38853016 |
| 108 | locomotory exploration behavior (GO:0035641) | 2.38802968 |
| 109 | alanine transport (GO:0032328) | 2.38713000 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.38350520 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 2.37505754 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.37498693 |
| 113 | negative regulation of interleukin-12 production (GO:0032695) | 2.36293311 |
| 114 | negative regulation of lipase activity (GO:0060192) | 2.35949128 |
| 115 | sulfur amino acid catabolic process (GO:0000098) | 2.35902784 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.35760801 |
| 117 | activation of protein kinase A activity (GO:0034199) | 2.34820236 |
| 118 | import into cell (GO:0098657) | 2.34240920 |
| 119 | embryonic process involved in female pregnancy (GO:0060136) | 2.33957640 |
| 120 | adhesion of symbiont to host cell (GO:0044650) | 2.33747411 |
| 121 | virion attachment to host cell (GO:0019062) | 2.33747411 |
| 122 | positive regulation of natural killer cell activation (GO:0032816) | 2.33412222 |
| 123 | negative regulation of lipid transport (GO:0032369) | 2.33360563 |
| 124 | positive regulation of glycolytic process (GO:0045821) | 2.33237659 |
| 125 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.32996707 |
| 126 | endoplasmic reticulum organization (GO:0007029) | 2.31960994 |
| 127 | extracellular matrix assembly (GO:0085029) | 2.31882295 |
| 128 | fatty acid homeostasis (GO:0055089) | 2.31848995 |
| 129 | tyrosine metabolic process (GO:0006570) | 2.31053282 |
| 130 | fatty acid transmembrane transport (GO:1902001) | 2.30890218 |
| 131 | protein-lipid complex subunit organization (GO:0071825) | 2.30515597 |
| 132 | linoleic acid metabolic process (GO:0043651) | 2.30254481 |
| 133 | regulation of necroptotic process (GO:0060544) | 2.30051256 |
| 134 | synaptic vesicle maturation (GO:0016188) | 2.29695232 |
| 135 | regulation of cholesterol storage (GO:0010885) | 2.28214567 |
| 136 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.27878202 |
| 137 | regulation of protein polyubiquitination (GO:1902914) | 2.27605923 |
| 138 | lipoprotein metabolic process (GO:0042157) | 2.25579501 |
| 139 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.25363412 |
| 140 | venous blood vessel morphogenesis (GO:0048845) | 2.24605742 |
| 141 | bile acid and bile salt transport (GO:0015721) | 2.24371594 |
| 142 | establishment of nucleus localization (GO:0040023) | 2.24205369 |
| 143 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.24082062 |
| 144 | regulation of lipid catabolic process (GO:0050994) | 2.23726479 |
| 145 | cellular potassium ion homeostasis (GO:0030007) | 2.22766217 |
| 146 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.21423382 |
| 147 | plasma lipoprotein particle organization (GO:0071827) | 2.21289149 |
| 148 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.19491273 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19458144 |
| 150 | negative regulation of fatty acid transport (GO:2000192) | 2.19274185 |
| 151 | macrophage activation involved in immune response (GO:0002281) | 2.17794462 |
| 152 | response to laminar fluid shear stress (GO:0034616) | 2.16790701 |
| 153 | endocardial cushion development (GO:0003197) | 2.16689973 |
| 154 | regulation of extracellular matrix disassembly (GO:0010715) | 2.16382624 |
| 155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.14713627 |
| 156 | cortical cytoskeleton organization (GO:0030865) | 2.13828954 |
| 157 | negative regulation of osteoblast proliferation (GO:0033689) | 2.13607499 |
| 158 | mesodermal cell differentiation (GO:0048333) | 2.12341006 |
| 159 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.11427465 |
| 160 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.08915500 |
| 161 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.07855790 |
| 162 | cellular response to vitamin (GO:0071295) | 2.07652229 |
| 163 | smooth muscle tissue development (GO:0048745) | 2.07272152 |
| 164 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.05826416 |
| 165 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.05647837 |
| 166 | response to fluid shear stress (GO:0034405) | 2.05343100 |
| 167 | germinal center formation (GO:0002467) | 2.04810256 |
| 168 | regulation of macrophage cytokine production (GO:0010935) | 2.04611869 |
| 169 | regulation of early endosome to late endosome transport (GO:2000641) | 2.04454170 |
| 170 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.03891174 |
| 171 | regulation of anoikis (GO:2000209) | 2.03765377 |
| 172 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.02579542 |
| 173 | blood vessel maturation (GO:0001955) | 2.02518143 |
| 174 | response to muramyl dipeptide (GO:0032495) | 2.01224411 |
| 175 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.00723541 |
| 176 | hyaluronan catabolic process (GO:0030214) | 2.00131666 |
| 177 | response to peptidoglycan (GO:0032494) | 2.00066427 |
| 178 | oligosaccharide catabolic process (GO:0009313) | 1.99453672 |
| 179 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 1.99225583 |
| 180 | negative regulation of cell killing (GO:0031342) | 1.98331188 |
| 181 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.98331188 |
| 182 | regulation of transforming growth factor beta1 production (GO:0032908) | 1.98240820 |
| 183 | apoptotic cell clearance (GO:0043277) | 1.98135065 |
| 184 | positive regulation of macrophage cytokine production (GO:0060907) | 1.95927566 |
| 185 | sprouting angiogenesis (GO:0002040) | 1.94948920 |
| 186 | kidney mesenchyme development (GO:0072074) | 1.94900635 |
| 187 | collagen metabolic process (GO:0032963) | 1.94625630 |
| 188 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.94607406 |
| 189 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 1.94495233 |
| 190 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.94396613 |
| 191 | cellular extravasation (GO:0045123) | 1.94267275 |
| 192 | SMAD protein complex assembly (GO:0007183) | 1.93880438 |
| 193 | cell-substrate adherens junction assembly (GO:0007045) | 1.93433657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.06606424 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17790437 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05934094 |
| 4 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.76656534 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70740860 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.68169986 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39025232 |
| 8 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.22958540 |
| 9 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.13439716 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12480360 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12099491 |
| 12 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.99689395 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93984523 |
| 14 | CJUN_26792858_Chip-Seq_BT549_Human | 1.91581267 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90206952 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87004547 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86296687 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85832611 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85574186 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85090646 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84223353 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77414750 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75572784 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70255012 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69505646 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69106453 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66304314 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64867416 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60866968 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60028152 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55978158 |
| 32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53705279 |
| 33 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53705279 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46795641 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45404027 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44545571 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43787903 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43372167 |
| 39 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42508536 |
| 40 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40491700 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40088543 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.39606697 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38956518 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38630262 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38276003 |
| 46 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.37629357 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37459110 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37380836 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37219418 |
| 50 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.35589909 |
| 51 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33880823 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33070044 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.32365564 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31831604 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31284897 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30463739 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28711553 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28145547 |
| 59 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27580958 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27298164 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25693089 |
| 62 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25576278 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23606915 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22751556 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19596257 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19076876 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18341267 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17490339 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17104492 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16707373 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16653514 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15965318 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15370396 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14314969 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14235842 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11415122 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11354439 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10839213 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10487070 |
| 80 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10166924 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09683023 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08677051 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06650155 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06344195 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06344195 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05986465 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05834500 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05565080 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04626261 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04518773 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04460130 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04354323 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04174324 |
| 94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03797069 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03712500 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03106322 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02988217 |
| 98 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01795513 |
| 99 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01091461 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00740482 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.00543438 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00362504 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00270281 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00268122 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.99734949 |
| 106 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98644834 |
| 107 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98429997 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98201601 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98069307 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97882887 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97811511 |
| 112 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97554558 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96086457 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94454147 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94256191 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93931415 |
| 117 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92873002 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92124704 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91551410 |
| 120 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91469964 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90527461 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90138691 |
| 123 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.89021898 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88814074 |
| 125 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88482371 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87986747 |
| 127 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87962667 |
| 128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87700906 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87634011 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87578306 |
| 131 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86711625 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86598312 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86598312 |
| 134 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86542988 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86532103 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85563525 |
| 137 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83903749 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82449599 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81105550 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80356669 |
| 141 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79480457 |
| 142 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79362719 |
| 143 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79144523 |
| 144 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78338686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.17080433 |
| 2 | MP0005360_urolithiasis | 5.03860308 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.96123154 |
| 4 | MP0000569_abnormal_digit_pigmentation | 4.80087127 |
| 5 | MP0005365_abnormal_bile_salt | 3.97552536 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.48213866 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.47986133 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.37667325 |
| 9 | MP0003252_abnormal_bile_duct | 3.27311084 |
| 10 | MP0006054_spinal_hemorrhage | 2.91731914 |
| 11 | MP0003279_aneurysm | 2.85859666 |
| 12 | MP0005275_abnormal_skin_tensile | 2.85576163 |
| 13 | MP0001958_emphysema | 2.84738794 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.70376590 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.49531252 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.43681262 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.33803890 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.29938677 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.28519311 |
| 20 | MP0009840_abnormal_foam_cell | 2.21594390 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.05213478 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.99623460 |
| 23 | MP0004130_abnormal_muscle_cell | 1.98778790 |
| 24 | MP0004272_abnormal_basement_membrane | 1.96538742 |
| 25 | MP0005451_abnormal_body_composition | 1.94700585 |
| 26 | MP0005023_abnormal_wound_healing | 1.89517983 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.89268895 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.88793381 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.88557361 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.81751179 |
| 31 | MP0003045_fibrosis | 1.81095578 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.77333735 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.74060137 |
| 34 | MP0000609_abnormal_liver_physiology | 1.71309894 |
| 35 | MP0003828_pulmonary_edema | 1.67901888 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.64889966 |
| 37 | MP0003436_decreased_susceptibility_to | 1.62661877 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.59857565 |
| 39 | MP0003868_abnormal_feces_composition | 1.58887142 |
| 40 | MP0001542_abnormal_bone_strength | 1.55442297 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.54718336 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.51754561 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.50663982 |
| 44 | MP0005670_abnormal_white_adipose | 1.49897595 |
| 45 | MP0003690_abnormal_glial_cell | 1.48867125 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.46064906 |
| 47 | MP0000604_amyloidosis | 1.42368292 |
| 48 | MP0006082_CNS_inflammation | 1.40453805 |
| 49 | MP0003724_increased_susceptibility_to | 1.40352581 |
| 50 | MP0005164_abnormal_response_to | 1.38805481 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.38634650 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.38585143 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.30926083 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.30831653 |
| 55 | MP0000733_abnormal_muscle_development | 1.30564599 |
| 56 | MP0005171_absent_coat_pigmentation | 1.30364254 |
| 57 | MP0003448_altered_tumor_morphology | 1.26322931 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.22862048 |
| 59 | MP0005083_abnormal_biliary_tract | 1.21702986 |
| 60 | MP0003195_calcinosis | 1.21071250 |
| 61 | MP0002060_abnormal_skin_morphology | 1.19893312 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.18510659 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.16053162 |
| 64 | MP0002419_abnormal_innate_immunity | 1.15638632 |
| 65 | MP0005409_darkened_coat_color | 1.15236657 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.14839435 |
| 67 | MP0005332_abnormal_amino_acid | 1.14373759 |
| 68 | MP0004883_abnormal_blood_vessel | 1.14123486 |
| 69 | MP0004947_skin_inflammation | 1.12905442 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.12313466 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.10640160 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.10346084 |
| 73 | MP0010307_abnormal_tumor_latency | 1.10268538 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.09986759 |
| 75 | MP0003941_abnormal_skin_development | 1.08449686 |
| 76 | MP0002254_reproductive_system_inflammat | 1.08209734 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.07501500 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05182021 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 1.04962799 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.04251131 |
| 81 | MP0003303_peritoneal_inflammation | 1.03903886 |
| 82 | MP0005334_abnormal_fat_pad | 1.03742248 |
| 83 | MP0003329_amyloid_beta_deposits | 1.01729307 |
| 84 | MP0001243_abnormal_dermal_layer | 1.01349006 |
| 85 | MP0003763_abnormal_thymus_physiology | 1.00218730 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.99759082 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 0.99657843 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.99551470 |
| 89 | MP0000685_abnormal_immune_system | 0.99376002 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.98591667 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.98229053 |
| 92 | MP0002090_abnormal_vision | 0.98005679 |
| 93 | MP0005387_immune_system_phenotype | 0.97590737 |
| 94 | MP0001790_abnormal_immune_system | 0.97590737 |
| 95 | MP0003633_abnormal_nervous_system | 0.96814836 |
| 96 | MP0000749_muscle_degeneration | 0.96790505 |
| 97 | MP0008004_abnormal_stomach_pH | 0.96333167 |
| 98 | MP0002933_joint_inflammation | 0.96074515 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.94179215 |
| 100 | MP0008260_abnormal_autophagy | 0.94072403 |
| 101 | MP0005535_abnormal_body_temperature | 0.94038088 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.93305429 |
| 103 | MP0009697_abnormal_copulation | 0.92860356 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.92009660 |
| 105 | MP0002006_tumorigenesis | 0.91793212 |
| 106 | MP0003075_altered_response_to | 0.91347393 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.91217535 |
| 108 | MP0002971_abnormal_brown_adipose | 0.91060868 |
| 109 | MP0005390_skeleton_phenotype | 0.90470490 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.89051830 |
| 111 | MP0001915_intracranial_hemorrhage | 0.88608974 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.88437032 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.88394977 |
| 114 | MP0002928_abnormal_bile_duct | 0.87579146 |
| 115 | MP0004270_analgesia | 0.87541761 |
| 116 | MP0003091_abnormal_cell_migration | 0.87418021 |
| 117 | MP0002168_other_aberrant_phenotype | 0.87416763 |
| 118 | MP0009785_altered_susceptibility_to | 0.85438804 |
| 119 | MP0003787_abnormal_imprinting | 0.85339310 |
| 120 | MP0002822_catalepsy | 0.85297067 |
| 121 | MP0005621_abnormal_cell_physiology | 0.84898839 |
| 122 | MP0000858_altered_metastatic_potential | 0.83992223 |
| 123 | MP0002405_respiratory_system_inflammati | 0.83243021 |
| 124 | MP0005647_abnormal_sex_gland | 0.82616081 |
| 125 | MP0001177_atelectasis | 0.82418480 |
| 126 | MP0004233_abnormal_muscle_weight | 0.81972204 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.81490825 |
| 128 | MP0000371_diluted_coat_color | 0.81397079 |
| 129 | MP0002108_abnormal_muscle_morphology | 0.80646723 |
| 130 | MP0009672_abnormal_birth_weight | 0.79988729 |
| 131 | MP0004134_abnormal_chest_morphology | 0.79617675 |
| 132 | MP0000598_abnormal_liver_morphology | 0.76695337 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.76685905 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.76228837 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.76228837 |
| 136 | MP0002063_abnormal_learning/memory/cond | 0.75647747 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.75272986 |
| 138 | MP0009046_muscle_twitch | 0.74548187 |
| 139 | MP0005508_abnormal_skeleton_morphology | 0.74394432 |
| 140 | MP0001501_abnormal_sleep_pattern | 0.73905421 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73724338 |
| 142 | MP0001851_eye_inflammation | 0.73393201 |
| 143 | MP0005025_abnormal_response_to | 0.72822542 |
| 144 | MP0000249_abnormal_blood_vessel | 0.71870624 |
| 145 | MP0005448_abnormal_energy_balance | 0.71853175 |
| 146 | MP0009764_decreased_sensitivity_to | 0.71842050 |
| 147 | MP0002148_abnormal_hypersensitivity_rea | 0.71700637 |
| 148 | MP0002128_abnormal_blood_circulation | 0.71484558 |
| 149 | MP0000751_myopathy | 0.71262682 |
| 150 | MP0000427_abnormal_hair_cycle | 0.70384442 |
| 151 | MP0002723_abnormal_immune_serum | 0.70326629 |
| 152 | MP0003631_nervous_system_phenotype | 0.68624229 |
| 153 | MP0004510_myositis | 0.67818291 |
| 154 | MP0003566_abnormal_cell_adhesion | 0.67664400 |
| 155 | MP0004019_abnormal_vitamin_homeostasis | 0.67598770 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.66954668 |
| 157 | MP0009115_abnormal_fat_cell | 0.66676963 |
| 158 | MP0001299_abnormal_eye_distance/ | 0.65200363 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.64780824 |
| 160 | MP0001881_abnormal_mammary_gland | 0.64154384 |
| 161 | MP0008874_decreased_physiological_sensi | 0.62965585 |
| 162 | MP0002877_abnormal_melanocyte_morpholog | 0.62257919 |
| 163 | MP0008569_lethality_at_weaning | 0.61109044 |
| 164 | MP0000747_muscle_weakness | 0.60857817 |
| 165 | MP0002064_seizures | 0.60782067 |
| 166 | MP0005167_abnormal_blood-brain_barrier | 0.58337883 |
| 167 | MP0001661_extended_life_span | 0.58155150 |
| 168 | MP0009384_cardiac_valve_regurgitation | 0.57902115 |
| 169 | MP0001873_stomach_inflammation | 0.57698208 |
| 170 | MP0005310_abnormal_salivary_gland | 0.56783277 |
| 171 | MP0005220_abnormal_exocrine_pancreas | 0.56712175 |
| 172 | MP0002269_muscular_atrophy | 0.56363056 |
| 173 | MP0009763_increased_sensitivity_to | 0.55867623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.54664869 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.03729917 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.03571845 |
| 4 | Aortic dissection (HP:0002647) | 3.84073003 |
| 5 | Spondylolisthesis (HP:0003302) | 3.83942401 |
| 6 | Vascular tortuosity (HP:0004948) | 3.76096210 |
| 7 | Arterial tortuosity (HP:0005116) | 3.59275738 |
| 8 | Xanthomatosis (HP:0000991) | 3.34884258 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.33803099 |
| 10 | Epidermoid cyst (HP:0200040) | 3.07570342 |
| 11 | Complement deficiency (HP:0004431) | 3.07562558 |
| 12 | Cervical subluxation (HP:0003308) | 3.00016399 |
| 13 | Myocardial infarction (HP:0001658) | 2.93184573 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 2.87883534 |
| 15 | Macroorchidism (HP:0000053) | 2.87393087 |
| 16 | Osteolytic defects of the hand bones (HP:0009699) | 2.85160398 |
| 17 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.85160398 |
| 18 | Dilatation of the ascending aorta (HP:0005111) | 2.82997279 |
| 19 | Peritonitis (HP:0002586) | 2.82254954 |
| 20 | Ankle contracture (HP:0006466) | 2.80236819 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.78197654 |
| 22 | Acanthocytosis (HP:0001927) | 2.77619859 |
| 23 | Follicular hyperkeratosis (HP:0007502) | 2.76447892 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 2.71400473 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.70672294 |
| 26 | Wormian bones (HP:0002645) | 2.70655060 |
| 27 | Overgrowth (HP:0001548) | 2.69445959 |
| 28 | Syringomyelia (HP:0003396) | 2.59500032 |
| 29 | Spinal cord lesions (HP:0100561) | 2.59500032 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.58899845 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.57019705 |
| 32 | Soft skin (HP:0000977) | 2.53629349 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53506906 |
| 34 | Slender build (HP:0001533) | 2.50116090 |
| 35 | Genu recurvatum (HP:0002816) | 2.49272893 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48913395 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48913395 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48913395 |
| 39 | Skin nodule (HP:0200036) | 2.45503622 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.44330777 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42421758 |
| 42 | Atrophic scars (HP:0001075) | 2.41938921 |
| 43 | Broad metatarsal (HP:0001783) | 2.41371894 |
| 44 | Thoracolumbar scoliosis (HP:0002944) | 2.41366111 |
| 45 | Postural instability (HP:0002172) | 2.40705931 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.39906391 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.38836692 |
| 48 | Spinal rigidity (HP:0003306) | 2.34351627 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.34031389 |
| 50 | Aortic regurgitation (HP:0001659) | 2.33736081 |
| 51 | Dysmetric saccades (HP:0000641) | 2.33409369 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.32718947 |
| 53 | Hematochezia (HP:0002573) | 2.30368815 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.30005519 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28772919 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27133332 |
| 57 | Mitral stenosis (HP:0001718) | 2.26767908 |
| 58 | Poikilocytosis (HP:0004447) | 2.19992257 |
| 59 | Joint hemorrhage (HP:0005261) | 2.18555940 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.17995099 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17995099 |
| 62 | Abnormality of complement system (HP:0005339) | 2.17376127 |
| 63 | Absent frontal sinuses (HP:0002688) | 2.17047187 |
| 64 | Bladder diverticulum (HP:0000015) | 2.17017989 |
| 65 | Joint laxity (HP:0001388) | 2.16694919 |
| 66 | Ovoid vertebral bodies (HP:0003300) | 2.15771698 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.15090230 |
| 68 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.13604757 |
| 69 | Cerebral aneurysm (HP:0004944) | 2.07199412 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.06571957 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.03833315 |
| 72 | Hemiplegia (HP:0002301) | 2.02613012 |
| 73 | Resting tremor (HP:0002322) | 2.01332892 |
| 74 | Neonatal short-limb short stature (HP:0008921) | 2.00651453 |
| 75 | Aneurysm (HP:0002617) | 2.00130476 |
| 76 | Subacute progressive viral hepatitis (HP:0006572) | 2.00031013 |
| 77 | Mitral regurgitation (HP:0001653) | 1.99836731 |
| 78 | Hypoplasia of the iris (HP:0007676) | 1.99193106 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 1.99025089 |
| 80 | Upper limb amyotrophy (HP:0009129) | 1.99025089 |
| 81 | Broad ribs (HP:0000885) | 1.98899067 |
| 82 | Thin bony cortex (HP:0002753) | 1.98463098 |
| 83 | Hypercholesterolemia (HP:0003124) | 1.97933527 |
| 84 | Blue sclerae (HP:0000592) | 1.97618568 |
| 85 | Flared iliac wings (HP:0002869) | 1.97157317 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95466439 |
| 87 | Dislocated radial head (HP:0003083) | 1.95371035 |
| 88 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.94720164 |
| 89 | Relative macrocephaly (HP:0004482) | 1.94379511 |
| 90 | Long eyelashes (HP:0000527) | 1.94000774 |
| 91 | Status epilepticus (HP:0002133) | 1.93523419 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93208009 |
| 93 | Focal seizures (HP:0007359) | 1.92532281 |
| 94 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92443326 |
| 95 | Abnormal social behavior (HP:0012433) | 1.92312561 |
| 96 | Impaired social interactions (HP:0000735) | 1.92312561 |
| 97 | Persistence of primary teeth (HP:0006335) | 1.91652146 |
| 98 | Ketosis (HP:0001946) | 1.90673610 |
| 99 | Frequent falls (HP:0002359) | 1.90188080 |
| 100 | Global brain atrophy (HP:0002283) | 1.89111457 |
| 101 | Hand muscle atrophy (HP:0009130) | 1.88035892 |
| 102 | Hypoglycemic seizures (HP:0002173) | 1.87921516 |
| 103 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.86610362 |
| 104 | Turricephaly (HP:0000262) | 1.86503098 |
| 105 | Shallow orbits (HP:0000586) | 1.86269858 |
| 106 | Fat malabsorption (HP:0002630) | 1.85879714 |
| 107 | Orchitis (HP:0100796) | 1.85733708 |
| 108 | Increased connective tissue (HP:0009025) | 1.84973921 |
| 109 | Long toe (HP:0010511) | 1.84268632 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.83665911 |
| 111 | Aortic aneurysm (HP:0004942) | 1.83198880 |
| 112 | Asymmetric septal hypertrophy (HP:0001670) | 1.82063413 |
| 113 | Cholelithiasis (HP:0001081) | 1.81166261 |
| 114 | Spontaneous hematomas (HP:0007420) | 1.79897403 |
| 115 | Short nail (HP:0001799) | 1.79279778 |
| 116 | Aortic valve stenosis (HP:0001650) | 1.77893933 |
| 117 | Hyperextensible skin (HP:0000974) | 1.75993669 |
| 118 | Intention tremor (HP:0002080) | 1.75968791 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.75601722 |
| 120 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74910684 |
| 121 | Hypoplasia of the thymus (HP:0000778) | 1.74421859 |
| 122 | Fragile skin (HP:0001030) | 1.73687139 |
| 123 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73643633 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.73602805 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.73602805 |
| 126 | Eczematoid dermatitis (HP:0000976) | 1.72730409 |
| 127 | Action tremor (HP:0002345) | 1.72189840 |
| 128 | Esophageal varix (HP:0002040) | 1.71989855 |
| 129 | Abnormality of the radial head (HP:0003995) | 1.71390855 |
| 130 | Mitral valve prolapse (HP:0001634) | 1.71163399 |
| 131 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.69978764 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.69828279 |
| 133 | Abnormality of the Achilles tendon (HP:0005109) | 1.69772721 |
| 134 | Coarse hair (HP:0002208) | 1.69752821 |
| 135 | Sensorimotor neuropathy (HP:0007141) | 1.69648241 |
| 136 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69532934 |
| 137 | Upper motor neuron abnormality (HP:0002127) | 1.69413213 |
| 138 | Lower limb amyotrophy (HP:0007210) | 1.68782967 |
| 139 | Gingival bleeding (HP:0000225) | 1.67764492 |
| 140 | Myositis (HP:0100614) | 1.67684887 |
| 141 | Abnormality of skull ossification (HP:0002703) | 1.67312811 |
| 142 | Elbow flexion contracture (HP:0002987) | 1.66967362 |
| 143 | Narrow palate (HP:0000189) | 1.66374859 |
| 144 | Limb hypertonia (HP:0002509) | 1.65742700 |
| 145 | Broad face (HP:0000283) | 1.65671712 |
| 146 | Retrobulbar optic neuritis (HP:0100654) | 1.65568732 |
| 147 | Optic neuritis (HP:0100653) | 1.65568732 |
| 148 | Abnormal foot bone ossification (HP:0010675) | 1.65556012 |
| 149 | Hypoglycemic coma (HP:0001325) | 1.65258026 |
| 150 | Hyperglycemia (HP:0003074) | 1.64473640 |
| 151 | Hemorrhage of the eye (HP:0011885) | 1.62088514 |
| 152 | Reticulocytosis (HP:0001923) | 1.61800131 |
| 153 | Wrist flexion contracture (HP:0001239) | 1.61523432 |
| 154 | Increased mean platelet volume (HP:0011877) | 1.61515351 |
| 155 | Genetic anticipation (HP:0003743) | 1.61367244 |
| 156 | Abnormality of the acetabulum (HP:0003170) | 1.61251115 |
| 157 | Protuberant abdomen (HP:0001538) | 1.60336566 |
| 158 | Bowel diverticulosis (HP:0005222) | 1.60326312 |
| 159 | Abnormality of purine metabolism (HP:0004352) | 1.59528422 |
| 160 | Drooling (HP:0002307) | 1.58785252 |
| 161 | Excessive salivation (HP:0003781) | 1.58785252 |
| 162 | Abnormality of dentin (HP:0010299) | 1.58751179 |
| 163 | Lymphangioma (HP:0100764) | 1.58313241 |
| 164 | Hypoplastic ischia (HP:0003175) | 1.58290728 |
| 165 | Pseudobulbar signs (HP:0002200) | 1.58170763 |
| 166 | Aqueductal stenosis (HP:0002410) | 1.58071529 |
| 167 | Hepatocellular carcinoma (HP:0001402) | 1.57364553 |
| 168 | Hyporeflexia of lower limbs (HP:0002600) | 1.57013267 |
| 169 | Wide anterior fontanel (HP:0000260) | 1.56691750 |
| 170 | Vertebral arch anomaly (HP:0008438) | 1.56093529 |
| 171 | Joint stiffness (HP:0001387) | 1.55600081 |
| 172 | Abnormal platelet volume (HP:0011876) | 1.55289701 |
| 173 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.55144886 |
| 174 | Biconcave vertebral bodies (HP:0004586) | 1.54633838 |
| 175 | Mild short stature (HP:0003502) | 1.54622055 |
| 176 | * Heterotopia (HP:0002282) | 1.54060550 |
| 177 | Camptodactyly of toe (HP:0001836) | 1.53907402 |
| 178 | Distal lower limb amyotrophy (HP:0008944) | 1.53558522 |
| 179 | Visual hallucinations (HP:0002367) | 1.52803731 |
| 180 | Striae distensae (HP:0001065) | 1.50518067 |
| 181 | Spastic tetraparesis (HP:0001285) | 1.50421347 |
| 182 | Increased CSF protein (HP:0002922) | 1.50091712 |
| 183 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.50039719 |
| 184 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.50039719 |
| 185 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.50039719 |
| 186 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.49916941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 3.20222504 |
| 2 | SIK1 | 2.71517778 |
| 3 | NEK9 | 2.61753704 |
| 4 | TAOK3 | 2.38510950 |
| 5 | CAMK1D | 2.36749326 |
| 6 | DDR2 | 2.36160031 |
| 7 | MAP3K10 | 2.33996534 |
| 8 | LATS1 | 2.29498466 |
| 9 | TRIB3 | 2.27799372 |
| 10 | CAMK1G | 2.23299904 |
| 11 | PRPF4B | 2.09526758 |
| 12 | CDK12 | 1.99293592 |
| 13 | MAP3K9 | 1.94965308 |
| 14 | MYLK | 1.93860314 |
| 15 | TRPM7 | 1.89187049 |
| 16 | MAP2K3 | 1.87840808 |
| 17 | EEF2K | 1.87280091 |
| 18 | MAP3K13 | 1.86484134 |
| 19 | FRK | 1.84508034 |
| 20 | PIK3CG | 1.83015161 |
| 21 | RIPK1 | 1.81017184 |
| 22 | PKN2 | 1.77635327 |
| 23 | GRK7 | 1.74999485 |
| 24 | SGK3 | 1.73025082 |
| 25 | DAPK2 | 1.72074504 |
| 26 | MAP3K7 | 1.70884730 |
| 27 | NTRK3 | 1.67222973 |
| 28 | FGFR2 | 1.63736042 |
| 29 | PTK6 | 1.62988641 |
| 30 | TTN | 1.58099180 |
| 31 | JAK1 | 1.51578044 |
| 32 | SIK2 | 1.45899789 |
| 33 | PAK6 | 1.44199092 |
| 34 | INSRR | 1.43142160 |
| 35 | SGK2 | 1.42355198 |
| 36 | FGFR4 | 1.34797475 |
| 37 | PRKD2 | 1.32907829 |
| 38 | SCYL2 | 1.32201874 |
| 39 | ZAP70 | 1.32164440 |
| 40 | MAP3K2 | 1.31944526 |
| 41 | PRKCH | 1.31578346 |
| 42 | MAP3K6 | 1.31261281 |
| 43 | MAP3K3 | 1.30293268 |
| 44 | FGFR3 | 1.28809938 |
| 45 | CAMKK1 | 1.28663363 |
| 46 | MOS | 1.26483072 |
| 47 | MELK | 1.26416904 |
| 48 | PAK2 | 1.24834160 |
| 49 | TAOK1 | 1.23753973 |
| 50 | MAP3K4 | 1.20917369 |
| 51 | ERN1 | 1.17885029 |
| 52 | PRKD3 | 1.17398951 |
| 53 | RET | 1.11222986 |
| 54 | BLK | 1.10609614 |
| 55 | STK38 | 1.09400808 |
| 56 | PDGFRA | 1.06515008 |
| 57 | ACVR1B | 1.05998891 |
| 58 | EPHA4 | 1.05351580 |
| 59 | MAP2K4 | 1.02921380 |
| 60 | SGK494 | 1.02173291 |
| 61 | SGK223 | 1.02173291 |
| 62 | NLK | 1.01846822 |
| 63 | RIPK4 | 1.01620282 |
| 64 | KSR2 | 1.01605572 |
| 65 | KIT | 1.01502841 |
| 66 | MTOR | 1.01464423 |
| 67 | IKBKE | 0.96412446 |
| 68 | TNK2 | 0.95925467 |
| 69 | TBK1 | 0.93789376 |
| 70 | PDGFRB | 0.93023144 |
| 71 | JAK2 | 0.91663528 |
| 72 | MAP3K14 | 0.91320663 |
| 73 | STK3 | 0.90322606 |
| 74 | PRKAA1 | 0.89319767 |
| 75 | ICK | 0.89156153 |
| 76 | PDK1 | 0.88647094 |
| 77 | PTK2B | 0.86754647 |
| 78 | EPHA3 | 0.85741127 |
| 79 | TAOK2 | 0.84966203 |
| 80 | LMTK2 | 0.84791227 |
| 81 | TYK2 | 0.83702674 |
| 82 | SGK1 | 0.82242614 |
| 83 | NTRK1 | 0.82038259 |
| 84 | PRKAA2 | 0.80362488 |
| 85 | CSK | 0.79431678 |
| 86 | CDC42BPA | 0.79286655 |
| 87 | MARK2 | 0.78912535 |
| 88 | PAK3 | 0.78244250 |
| 89 | CHUK | 0.77389468 |
| 90 | CDK9 | 0.77369642 |
| 91 | CDK6 | 0.75561464 |
| 92 | PDPK1 | 0.73657104 |
| 93 | BRD4 | 0.73407784 |
| 94 | NTRK2 | 0.72884842 |
| 95 | ALK | 0.72533023 |
| 96 | JAK3 | 0.72356485 |
| 97 | STK11 | 0.71420408 |
| 98 | MAP3K1 | 0.70966290 |
| 99 | EPHB1 | 0.70128121 |
| 100 | MAP3K5 | 0.67274056 |
| 101 | MARK3 | 0.67002661 |
| 102 | HCK | 0.66829721 |
| 103 | WNK1 | 0.66483682 |
| 104 | STK10 | 0.65826395 |
| 105 | IRAK4 | 0.65299348 |
| 106 | MAPK11 | 0.62512224 |
| 107 | MAPK12 | 0.61780215 |
| 108 | RPS6KA2 | 0.61487156 |
| 109 | BMPR2 | 0.61324913 |
| 110 | TEC | 0.60549838 |
| 111 | ERBB4 | 0.60214942 |
| 112 | GRK6 | 0.59662488 |
| 113 | MAP4K1 | 0.57805684 |
| 114 | KSR1 | 0.57604689 |
| 115 | ERBB2 | 0.57520470 |
| 116 | FLT3 | 0.56005970 |
| 117 | BMX | 0.55792441 |
| 118 | RPS6KA3 | 0.55562285 |
| 119 | FES | 0.54526009 |
| 120 | CDK5 | 0.54281987 |
| 121 | PTK2 | 0.54253142 |
| 122 | PRKCZ | 0.54192064 |
| 123 | MAPK7 | 0.54172464 |
| 124 | LATS2 | 0.53912359 |
| 125 | TXK | 0.49811744 |
| 126 | GSK3A | 0.48020119 |
| 127 | ROCK1 | 0.47820725 |
| 128 | FGR | 0.47030792 |
| 129 | PKN1 | 0.46410370 |
| 130 | CLK1 | 0.45669009 |
| 131 | MAPK10 | 0.45666051 |
| 132 | MET | 0.45447547 |
| 133 | RAF1 | 0.44850000 |
| 134 | TGFBR2 | 0.44154391 |
| 135 | PHKG2 | 0.43907354 |
| 136 | PHKG1 | 0.43907354 |
| 137 | LCK | 0.43867499 |
| 138 | SYK | 0.43748113 |
| 139 | DYRK1B | 0.43398239 |
| 140 | DMPK | 0.43267739 |
| 141 | ROCK2 | 0.42719243 |
| 142 | FER | 0.42339429 |
| 143 | PRKD1 | 0.41587086 |
| 144 | IRAK3 | 0.40833699 |
| 145 | FGFR1 | 0.40112681 |
| 146 | HIPK2 | 0.40104654 |
| 147 | CAMK4 | 0.40080878 |
| 148 | MAPK8 | 0.40050434 |
| 149 | TYRO3 | 0.38975684 |
| 150 | FYN | 0.38772558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.16176778 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57590539 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50920776 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48663522 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.95641722 |
| 6 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.71341157 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 1.68542054 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.65433626 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65249445 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 1.61233713 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60953234 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54851030 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52092343 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51152508 |
| 15 | ABC transporters_Homo sapiens_hsa02010 | 1.50588321 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.47578811 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.47249432 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45222507 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41175269 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40136177 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40099186 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37519002 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35024814 |
| 24 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.34981638 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33221214 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.32694213 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31868727 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28124513 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25098125 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24890983 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23354024 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19454526 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18690193 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.17226727 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17116703 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16813303 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.16310266 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.14658415 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14557392 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.13643202 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13076127 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12250504 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.10014448 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.10000761 |
| 45 | Prostate cancer_Homo sapiens_hsa05215 | 1.07294680 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07087313 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06172666 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05862798 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05508541 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03219743 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02619282 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.02558943 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01938155 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01726019 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.01596884 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00268871 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.99741652 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98885759 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97670675 |
| 60 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97412138 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.95597659 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94951813 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94884504 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94189653 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93977311 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92723212 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92114290 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91727144 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91639288 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90557097 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89812881 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89587723 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89558533 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89319366 |
| 75 | Melanoma_Homo sapiens_hsa05218 | 0.88815142 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88381809 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88326118 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87812512 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.87772587 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87653389 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86256404 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.85696097 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.85624478 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83805306 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83651860 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81727181 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80988223 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80233444 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79126031 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.78946295 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.78697509 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77350421 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76961727 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76847253 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76639978 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.76288255 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.74832597 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74690662 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.74100237 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73684120 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72838307 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72204967 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.72159934 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71912850 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71476434 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71201688 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71053515 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69802986 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69319519 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69245677 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68801716 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68682794 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66385795 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65822989 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65794510 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.64890215 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64864676 |
| 118 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64597039 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.63345323 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63270622 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63187756 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.63174345 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62832179 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62118238 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61921030 |
| 126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61919357 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61872194 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60977665 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60850544 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59514280 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59139287 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58791733 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58103741 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.57713690 |
| 135 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57139213 |
| 136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57081190 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56931875 |
| 138 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55870390 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55709829 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55182532 |
| 141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52833508 |
| 142 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.51383084 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50900271 |
| 144 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50206002 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49847258 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49315844 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48932556 |
| 148 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48700160 |
| 149 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48156435 |
| 150 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46912490 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46886538 |
| 152 | Nicotine addiction_Homo sapiens_hsa05033 | 0.46504992 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45048142 |
| 154 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43458304 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43012157 |
| 156 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42156989 |
| 157 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42112424 |
| 158 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41616012 |
| 159 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41401761 |
| 160 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40564082 |
| 161 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40243528 |
| 162 | Platelet activation_Homo sapiens_hsa04611 | 0.39435068 |
| 163 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37479641 |
| 164 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37218359 |

